These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12134019)

  • 21. Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.
    Kumar AS; Reddi HV; Kung AY; Dal Canto M; Lipton HL
    J Virol; 2004 Aug; 78(16):8860-7. PubMed ID: 15280494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system.
    Lipton HL; Pritchard AE; Calenoff MA
    J Gen Virol; 1998 May; 79 ( Pt 5)():1001-4. PubMed ID: 9603314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis.
    Reddi HV; Kumar AS; Kung AY; Kallio PD; Schlitt BP; Lipton HL
    J Virol; 2004 Aug; 78(16):8909-16. PubMed ID: 15280499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
    Upfold N; Ross C; Bishop ÖT; Luke GA; Knox C
    Virus Res; 2018 Jan; 244():153-163. PubMed ID: 29155139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene.
    Tangy F; McAllister A; Aubert C; Brahic M
    J Virol; 1991 Mar; 65(3):1616-8. PubMed ID: 1844214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system.
    Jarousse N; Martinat C; Syan S; Brahic M; McAllister A
    J Virol; 1996 Nov; 70(11):8213-7. PubMed ID: 8892956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses.
    Reddi HV; Lipton HL
    J Virol; 2002 Aug; 76(16):8400-7. PubMed ID: 12134043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis.
    McCright IJ; Tsunoda I; Whitby FG; Fujinami RS
    J Virol; 1999 Apr; 73(4):2814-24. PubMed ID: 10074129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus.
    Aubert C; Brahic M
    J Virol; 1995 May; 69(5):3197-200. PubMed ID: 7707550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence.
    Stein SB; Zhang L; Roos RP
    J Virol; 1992 Jul; 66(7):4508-17. PubMed ID: 1602556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
    Adami C; Pritchard AE; Knauf T; Luo M; Lipton HL
    J Virol; 1998 Feb; 72(2):1662-5. PubMed ID: 9445074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The morphogenesis of Theiler's murine encephalomyelitis virus is strain specific.
    Steurbaut S; Vrijsen R
    Arch Virol; 2003 Jun; 148(6):1135-53. PubMed ID: 12756619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
    McCright IJ; Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2002 Apr; 8(2):100-10. PubMed ID: 11935462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus.
    Tsunoda I; Iwasaki Y; Terunuma H; Sako K; Ohara Y
    Acta Neuropathol; 1996; 91(6):595-602. PubMed ID: 8781658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus.
    Buckwalter MR; Nga PT; Gouilh MA; Fiette L; Bureau JF; Laird ME; Buchrieser J; Ozden S; Cheval J; Eloit M; Manuguerra JC; Gessain A; Brey PT; Fontanet A; Albert ML
    J Virol; 2011 Jul; 85(14):6893-905. PubMed ID: 21543488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells.
    Simas JP; Dyson H; Fazakerley JK
    J Virol; 1995 Sep; 69(9):5599-606. PubMed ID: 7637006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants of Theiler's murine encephalomyelitis-induced disease.
    Jakob J; Roos RP
    J Neurovirol; 1996 Apr; 2(2):70-7. PubMed ID: 8799198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system.
    Jarousse N; Viktorova EG; Pilipenko EV; Agol VI; Brahic M
    J Virol; 1999 Jan; 73(1):801-4. PubMed ID: 9847392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.
    Pevear DC; Borkowski J; Calenoff M; Oh CK; Ostrowski B; Lipton HL
    Virology; 1988 Jul; 165(1):1-12. PubMed ID: 2838951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.